Skip to main content
Top
Published in: World Journal of Surgery 9/2020

01-09-2020 | Liver Transplantation | Reply, Letter to the Editor

Authors’ Reply: Prognostic Impact of Osteopenia in Patients Who Underwent Living Donor Liver Transplantation for Hepatocellular Carcinoma

Authors: Takeo Toshima, Tomoharu Yoshizumi, Noboru Harada, Shinji Itoh, Masaki Mori

Published in: World Journal of Surgery | Issue 9/2020

Login to get access

Excerpt

Dear Professor Akbulut and colleagues: …
Literature
1.
go back to reference Toshima T, Yoshizumi T, Kosai-Fujimoto Y et al (2020) Prognostic impact of osteopenia in patients who underwent living donor liver transplantation for hepatocellular carcinoma. World J Surg 44:258–267CrossRef Toshima T, Yoshizumi T, Kosai-Fujimoto Y et al (2020) Prognostic impact of osteopenia in patients who underwent living donor liver transplantation for hepatocellular carcinoma. World J Surg 44:258–267CrossRef
2.
go back to reference Sharma P, Parikh ND, Yu J et al (2016) Bone mineral density predicts posttransplant survival among hepatocellular carcinoma liver transplant recipients. Liver Transpl 22:1092–1098CrossRef Sharma P, Parikh ND, Yu J et al (2016) Bone mineral density predicts posttransplant survival among hepatocellular carcinoma liver transplant recipients. Liver Transpl 22:1092–1098CrossRef
3.
go back to reference Toshima T, Yoshizumi T, Inokuchi S et al (2020) Risk factors for the metabolic syndrome components of hypertension, diabetes mellitus, and dyslipidemia after living donor liver transplantation. HPB (Oxford) 22:511–520CrossRef Toshima T, Yoshizumi T, Inokuchi S et al (2020) Risk factors for the metabolic syndrome components of hypertension, diabetes mellitus, and dyslipidemia after living donor liver transplantation. HPB (Oxford) 22:511–520CrossRef
4.
go back to reference Ikegami T, Ueda Y, Akamatsu N, et al (2017) Asunaprevir and daclatasvir for recurrent hepatitis C after liver transplantation: A Japanese multicenter experience. Clin Transpl 31 Ikegami T, Ueda Y, Akamatsu N, et al (2017) Asunaprevir and daclatasvir for recurrent hepatitis C after liver transplantation: A Japanese multicenter experience. Clin Transpl 31
5.
go back to reference Jeng LB, Lee SG, Soin AS et al (2018) Efficacy and safety of everolimus with reduced tacrolimus in living-donor liver transplant recipients: 12-month results of a randomized multicenter study. Am J Transpl 18:1435–1446CrossRef Jeng LB, Lee SG, Soin AS et al (2018) Efficacy and safety of everolimus with reduced tacrolimus in living-donor liver transplant recipients: 12-month results of a randomized multicenter study. Am J Transpl 18:1435–1446CrossRef
Metadata
Title
Authors’ Reply: Prognostic Impact of Osteopenia in Patients Who Underwent Living Donor Liver Transplantation for Hepatocellular Carcinoma
Authors
Takeo Toshima
Tomoharu Yoshizumi
Noboru Harada
Shinji Itoh
Masaki Mori
Publication date
01-09-2020
Publisher
Springer International Publishing
Published in
World Journal of Surgery / Issue 9/2020
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-020-05639-3

Other articles of this Issue 9/2020

World Journal of Surgery 9/2020 Go to the issue